Login to Your Account



Ampliphi Bioscience is set to start trial of a bacteriophage antibiotic

By Nuala Moran
Staff Writer

Friday, January 9, 2015
LONDON – Ampliphi Biosciences Corp. and its partner the U.S. Army are on the march to becoming the first to stage an FDA-approved trial of a bacteriophage antibiotic.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription